Watch CNBC’s full interview with Piper Sandler’s Michael Kantrowitz

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email In the series finale, Oprah Winfrey tells Suze she knew from the very first time she was on her show, that Suze was destined to do something special. 03:04 Sat, Mar 28 20159:05 PM EDT

Ali wants to know if she can afford to spend $1,758 on a Louis Vuitton Sully MM handbag.

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Jason Helfstein, Oppenheimer head of internet research, joins ‘Power Lunch’ to discuss positive expectations for Netflix’s earnings results, the cancelation reduction force of Netflix’s new ad tier, and Amazon’s adoption of live sports programming. 05:29 Tue, Oct 18 20222:56 PM EDT

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Bleakley’s Peter Boockvar says this event could turn the market into a ‘minefield.’ Will Saudi oil output dampen prices? And can gold shine again? With CNBC’s Seema Mody and the Futures Now traders, Jim Iuorio at the CME and Anthony Grisanti at…

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Harsh Kumar, Piper Sandler senior research analyst, joins ‘TechCheck’ to discuss Kumar’s hesitations around Micron’s stock, what would lessen his concerns around Micron and whether the Chips Act is baked in to his rating on Micron. 06:23 Wed, Mar 30 202211:34 AM…